| |
|
Form Serial Number: |
IS20260721E00062
|
| 1.
Date of relevant event: |
16/07/2026
(dd/mm/yyyy)
|
| 2.
Date when the substantial shareholder becomes aware of the relevant event / interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
02563 |
| 4.
Name of listed corporation: |
北京華昊中天生物醫藥股份有限公司 - B |
| 5.
Class of shares: |
Ordinary Shares |
| 6.
Number of issued shares in class: |
389,588,000 |
| 7.
Name of substantial shareholder (English) as printed on HKID Card/Passport: |
| (Surname) |
FU |
| (Other names) |
GANG |
|
|
|
| 10.
Name of substantial shareholder (Chinese): |
付鋼 |
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 14.
Details of relevant event: |
| |
Brief description of relevant event |
Capacity in which shares were/are held |
Number of shares bought/sold or involved |
Currency of transaction |
On Exchange |
Off Exchange |
| Before relevant event |
After relevant event |
Highest price (per share) |
Average price (per share) |
Average consideration (per share) |
Nature of consideration |
| Long position |
| 1101 | The percentage level of your interest in the shares has increased because:
you purchased the shares |
|
| 2201 | Interest of corporation controlled by you |
|
| 2201 | Interest of corporation controlled by you |
|
25,000,000 |
HKD |
|
4.0000 |
|
|
| Short position |
|
|
|
|
|
|
|
|
|
|
|
| 15.
Total shares immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 4,170,800 | 1.14 |
|
| |
| 16.
Total shares immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 29,170,800 | 7.49 |
|
| |
| 17.
Capacity in which interests disclosed in Box 16 are held: |
| Capacity code | Number of shares |
| 2201 | Interest of corporation controlled by you |
| |
|
| |
| 18.
Further information in respect of derivative interests: |
| Derivatives code | Number of shares |
| | |
|
| |
| 19.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
| |
| 20.
Further information in relation to interests of corporations controlled by substantial shareholder: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling shareholder | % control | Direct interest (Y/N) | Number of shares |
| 北京百洋同興管理咨詢有限公司 | Building 5, No. 20 Ping'an Road, Mentougou District, Beijing,China | 付鋼 | 100.00 | N | |
| 北京百洋匯康科技創新發展有限公司 | Building 5, No. 20 Ping'an Road, Mentougou District, Beijing,China | 北京百洋同興管理咨詢有限公司 | 52.00 | N | |
| Baheal Pharma Group Co., Ltd. | No. 88 Kaifeng Road, Shibei District, Qingdao, China | 北京百洋匯康科技創新發展有限公司 | 80.00 | N | |
| Qingdao Baheal Medical Inc. | No. 1 Building, 88 Tongbai Road, Shibei District, Qingdao City, China | Baheal Pharma Group Co., Ltd. | 67.22 | N | |
| Baheal Wellness Industry International Trading Limited | Unit 2116, 21/F, Mira Place Tower A, 132 Nathan Road, Tsim Sha Tsui, Kowloon, Hong Kong | Qingdao Baheal Medical Inc. | 100.00 | Y | |
|
| |
| 21.
Further information in relation to interests held by substantial shareholder jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 22.
Further information from a trustee, a beneficiary of a trust, or a person who has set up a discretionary trust: |
| Names of trust | Address | Status code | Number of shares |
| | | |
|
| |
| 23.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a substantial shareholder is interested under sections 317 and 318 | |
|
| |
| 24.
Supplementary information: |
|
| 25.
Log/Serial Number of the previous form: |
|
| 26.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 1: |
21/07/2026
(dd/mm/yyyy)
|
| |